Introduction: People with diabetes often develop diverse microvascular, macrovascular, and neuropathic complications. Diabetes named high disease because of its high prevalence, high incidence, chronicity and high cos...Introduction: People with diabetes often develop diverse microvascular, macrovascular, and neuropathic complications. Diabetes named high disease because of its high prevalence, high incidence, chronicity and high costs. Accurate projections of diabetes burden are essential for health planning so the aim of this study was to calculate the burden of diabetes in Razavikhorasan population, in Iran. Methodology: We used Disability Adjusted Life Years (DALYs) index using computer model (DisMod) for assessment of burden of diabetes and complications in Razavikhorasan province in Iran in year 2010-2011. Results: Burden of diabetes in Razavikhorasan population was 64,733 DALY in year 2010-2011. The total Years Life Lost (YLL) from diabetes mellitus was 62,883 (34,216 in men and 28,667 in women) due to premature death and the total Years Life Disability (YLD) was 1850. Conclusion: Diabetes mellitus and lesser forms of glucose intolerance can now be found in almost every population and epidemiological evidences suggest that, without effective prevention and control programs, diabetes will continue to increase and therefore advances in all levels of prevention may help reduce the number of people with diabetes.展开更多
Tuberculosis (TB) is known as a disease of poverty and declared as a global public health emergency by World Health Organization (WHO). Pulmonary tuberculosis is the most common type of TB and is a wasting disease. It...Tuberculosis (TB) is known as a disease of poverty and declared as a global public health emergency by World Health Organization (WHO). Pulmonary tuberculosis is the most common type of TB and is a wasting disease. It is expected that the patients who lost weight during the course of disease, will gain weight during successful treatment. So the aim of this study was to assess the body weight changes through the treatment and its possible association with treatment outcome in TB patients in Nishapur, an ancient city in Razavi Khorasan province in Iran. This is an observational analytical study. Patients were selected according to inclusion and exclusion criteria and available information. Treatment Protocol for all patients was Directly Observed Treatment, short Course Strategy (at least 6 months). All patients were weighed at the beginning of treatment, after two months and at the end of treatment. Outcome of treatment was classified into: cured, completed treatment, treatment failure and death. Then the impact of weight changes during treatment was compared in subgroups. From 874 patients, 819 patients (93.9%) were new cases, 48 (5.3%) relapse, 5 patients (0.6%) patients who did not complete their treatment and 2 (0.2%) had failed prior therapy. The most common symptoms in all patients were: cough, sputum, weight loss, fever, sweats, and hemoptysis. 8.1% of patients had radiologic signs and the most common signs were cavity (2.9%). The weight change during treatment was 2.91 ± 5.59 kg in cured group, 3.3 ± 3.29 kg in completed treatment group, 2.95 ± 5.59 kg in treatment failure group and 1.02 ± 3.27 in dead group respectively. These differences were statistically significant between the four groups (p < 0.03). We can conclude that body weight change can be used as a predictor for the treatment outcome.展开更多
文摘Introduction: People with diabetes often develop diverse microvascular, macrovascular, and neuropathic complications. Diabetes named high disease because of its high prevalence, high incidence, chronicity and high costs. Accurate projections of diabetes burden are essential for health planning so the aim of this study was to calculate the burden of diabetes in Razavikhorasan population, in Iran. Methodology: We used Disability Adjusted Life Years (DALYs) index using computer model (DisMod) for assessment of burden of diabetes and complications in Razavikhorasan province in Iran in year 2010-2011. Results: Burden of diabetes in Razavikhorasan population was 64,733 DALY in year 2010-2011. The total Years Life Lost (YLL) from diabetes mellitus was 62,883 (34,216 in men and 28,667 in women) due to premature death and the total Years Life Disability (YLD) was 1850. Conclusion: Diabetes mellitus and lesser forms of glucose intolerance can now be found in almost every population and epidemiological evidences suggest that, without effective prevention and control programs, diabetes will continue to increase and therefore advances in all levels of prevention may help reduce the number of people with diabetes.
文摘Tuberculosis (TB) is known as a disease of poverty and declared as a global public health emergency by World Health Organization (WHO). Pulmonary tuberculosis is the most common type of TB and is a wasting disease. It is expected that the patients who lost weight during the course of disease, will gain weight during successful treatment. So the aim of this study was to assess the body weight changes through the treatment and its possible association with treatment outcome in TB patients in Nishapur, an ancient city in Razavi Khorasan province in Iran. This is an observational analytical study. Patients were selected according to inclusion and exclusion criteria and available information. Treatment Protocol for all patients was Directly Observed Treatment, short Course Strategy (at least 6 months). All patients were weighed at the beginning of treatment, after two months and at the end of treatment. Outcome of treatment was classified into: cured, completed treatment, treatment failure and death. Then the impact of weight changes during treatment was compared in subgroups. From 874 patients, 819 patients (93.9%) were new cases, 48 (5.3%) relapse, 5 patients (0.6%) patients who did not complete their treatment and 2 (0.2%) had failed prior therapy. The most common symptoms in all patients were: cough, sputum, weight loss, fever, sweats, and hemoptysis. 8.1% of patients had radiologic signs and the most common signs were cavity (2.9%). The weight change during treatment was 2.91 ± 5.59 kg in cured group, 3.3 ± 3.29 kg in completed treatment group, 2.95 ± 5.59 kg in treatment failure group and 1.02 ± 3.27 in dead group respectively. These differences were statistically significant between the four groups (p < 0.03). We can conclude that body weight change can be used as a predictor for the treatment outcome.
